½ÃÀ庸°í¼­
»óǰÄÚµå
1520531

¼¼°èÀÇ ±¤°£¼·´ÜÃþÃÔ¿µ(OCT) ½ÃÀå º¸°í¼­ : À¯Çü, ±â¼ú, ¿ëµµ, Áö¿ªº°(2024³â-2032³â)

Optical Coherence Tomography Market Report by Type, Technology (Time Domain OCT, Frequency Domain OCT ), Application, and Region 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 136 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ±¤°£¼·´ÜÃþÃÔ¿µ(OCT) ½ÃÀå ±Ô¸ð´Â 2023³â 18¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº ½ÃÀåÀÌ 2032³â±îÁö 52¾ï ´Þ·¯¿¡ À̸¦ Àü¸ÁÀ̰í 2024³â°ú 2032³â »çÀÌ¿¡ 12.2%ÀÇ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù.

±¤°£¼·´ÜÃþÃÔ¿µ(OCT)Àº ¸Á¸·ÀÇ °íÇØ»óµµ ´Ü¸é À̹ÌÁö¸¦ ¾ò´Â µ¥ »ç¿ëµÇ´Â ºñħ½ÀÀû À̹Ì¡ ±â¼úÀÔ´Ï´Ù. Ź»óÇü°ú ÇÚµåÇïµåÇüÀÌ ÀϹÝÀûÀ¸·Î ÀÌ¿ë °¡´ÉÇÑ OCT ÀåÄ¡ÀÇ À¯ÇüÀÔ´Ï´Ù. À̵éÀº °£¼·°è¿Í ³·Àº Àϰü¼º°ú ±¤´ë¿ª ´Ü ÆÞ½º ·¹ÀÌÀú ±¤¿øÀ¸·Î ±¸¼ºµÇ¾î ÀÖ½À´Ï´Ù. OCT´Â ¾È°ú, Á¾¾ç°ú, ½ÉÀåÇ÷°ü°ú, ÇǺΰú¿Í °°Àº ´Ù¾çÇÑ °Ç°­ °ü¸® ºÐ¾ß¿¡¼­ ³Î¸® »ç¿ëµË´Ï´Ù. ¶ÇÇÑ ¸Á¸·ÀÇ µÎ²²¸¦ °¨ÁöÇÏ°í ¸Á¸·ÀÇ Áúº´°ú »óŸ¦ Á¶±â¿¡ ¹ß°ßÇϰí Áø´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ÃßÀû °Ë»ç¿¡¼­ ½Å»ý ³»¸· ½ºÅÙÆ® ½ºÆ®·µÀÇ ÄÚÆÃÀ» Á¤È®ÇÏ°Ô ¿µ»óÈ­Çϰí Ç÷°ü º®¿¡ ½ºÅÙÆ® ½ºÆ®·µÀÇ ºÎÂøÀ» ½±°Ô Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù.

±¤°£¼·´ÜÃþÃÔ¿µ ½ÃÀå µ¿Çâ :

¼¼°è¿¡¼­ ¸Á¸·°ú ¸Æ¶ô¸·ÀÇ Àå¾Ö¿Í ½Ã°¢ Àå¾Ö°¡ Áõ°¡Çϰí ÀÖ´Â °ÍÀº ½ÃÀå¿¡ ¹àÀº Àü¸ÁÀ» °¡Á®¿À°í ÀÖ½À´Ï´Ù. ±¤°£¼· ´ÜÃþ°è´Â ¿­°ø,¹Ú¸®, ´ç´¢º´ ¸Á¸·Áõ, Ȳ¹Ý¿ø°ø, ¸Á¸· »ö¼Ò º¯¼ºÁõ µîÀÇ ¸Á¸· °ü·Ã ÁúȯÀÇ ½ºÅ©¸®´×À̳ª Áø´Ü¿¡ ¾È°ú Àǻ翡 ÀÇÇØ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. À̿ʹ º°µµ·Î Á¤¹Ðµµ Çâ»ó°ú ¾È°ú ÀÇ·á ÀüüÀÇ Áú Çâ»óÀ» Áö¿øÇÏ´Â °í¼º´É ±â±âÀÇ µµÀÔ µî ´Ù¾çÇÑ Á¦Ç° Çõ½ÅÀÌ ½ÃÀå ¼ºÀå¿¡ ź·ÂÀ» ÁÖ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ³ë³â Àα¸ Áõ°¡¿Í ¾Ï Áõ°¡µµ ½ÃÀå ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ±¤°£¼· ´ÜÃþ°è´Â ¾ÏÀÇ Á¶±â ¹ß°ß¿¡ µµ¿òÀÌ µÇ¾î ÇÙ ´ë ¼¼Æ÷Áúºñ, ÇÙÀÇ Å©±â¿Í ÇüÅÂ, ¶¡»ùÀÇ Á¶Á÷°ú ±¸Á¶¿¡ ´ëÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. ±× ¹Û¿¡ Á¶±âÁø´Ü¹ý¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¾à¹°Àü´Þ¿¡ À־ÀÇ Á¦Ç°ÀÇ ÀÌ¿ë È®´ë, ÇコÄÉ¾î ±â¼úÀÇ ´ëÆøÀûÀÎ Çâ»ó µîÀÌ ½ÃÀåÀÇ Ãß°¡ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

  • 2023³â ¼¼°èÀÇ ±¤°£¼·´ÜÃþÃÔ¿µ(OCT) ½ÃÀå ±Ô¸ð´Â?
  • 2024-2032³â ¼¼°èÀÇ ±¤°£¼·´ÜÃþÃÔ¿µ(OCT) ½ÃÀåÀÇ ¿¹»ó ¼ºÀå·üÀº?
  • ¼¼°èÀÇ ±¤°£¼·´ÜÃþÃÔ¿µ(OCT) ½ÃÀå¿¡ ÁØ COVID-19ÀÇ ¿µÇâÀº?
  • ¼¼°èÀÇ ±¤°£¼·´ÜÃþÃÔ¿µ(OCT) ½ÃÀåÀ» °ßÀÎÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?
  • ¼¼°èÀÇ ±¤°£¼·´ÜÃþÃÔ¿µ(OCT) ½ÃÀåÀ¯Çüº° ³»¿ªÀº? ¼¼°èÀÇ ±¤°£¼·´ÜÃþÃÔ¿µ(OCT) ½ÃÀåÀÇ ¿ëµµº° ³»¿ªÀº?
  • ¼¼°èÀÇ ºû Àϰü¼º ½ºÅä¸ð±×·¡ÇÇ ½ÃÀåÀÇ ÁÖ¿ä Áö¿ªÀº?
  • ¼¼°èÀÇ ºû ÄÚÈ÷¾î·±½º Åä¸ð±×·¡ÇÇ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»çÀÇ ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • »óÇâ½Ä Á¢±Ù
    • ÇÏÇâ½Ä Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

  • °³¿ä
  • ÁÖ¿ä ¾÷°è µ¿Çâ

Á¦5Àå ¼¼°èÀÇ ±¤°£¼·´ÜÃþÃÔ¿µ(OCT) ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ºÐ¼® : À¯Çüº°

  • ÇÚµåÇïµå OCT µð¹ÙÀ̽º
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • Ź»ó OCT ÀåÄ¡
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ±âŸ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦7Àå ½ÃÀå ºÐ¼® : ±â¼úº°

  • ½Ã°£ ¿µ¿ª OCT(TDOCT)
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • Á֯ļö ¿µ¿ª OCT(FD-OCT)
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦8Àå ½ÃÀå ºÐ¼® : ¿ëµµº°

  • ÇǺÎ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ¾È°ú
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ½ÉÀåÇ÷°ü
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • Á¾¾ç
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ±âŸ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦9Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ºÐ¼® : ±¹°¡º°
    • ½ÃÀå ¿¹Ãø

Á¦10Àå SWOT ºÐ¼®

  • °³¿ä
  • °­Á¡
  • ¾àÁ¡
  • ±âȸ
  • À§Çù

Á¦11Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦12Àå Porter's Five Forces ºÐ¼®

  • °³¿ä
  • ±¸¸ÅÀÚÀÇ Çù»ó·Â
  • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
  • °æÀïµµ
  • ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦13Àå °¡°Ý ºÐ¼®

Á¦14Àå °æÀï ±¸µµ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Abbott Laboratories
    • Agfa-Gevaert NV
    • Agiltron Inc.
    • Carl Zeiss AG
    • Haag-Streit Group
    • Heidelberg Engineering Inc.
    • Leica Microsystems GmbH(Danaher Corporation)
    • Novacam Technologies Inc.
    • OPTOPOL Technology Sp. z oo
    • Terumo Corporation
    • Thorlabs Inc.
    • Topcon Corporation
BJH 24.08.21

The global optical coherence tomography market size reached US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.2 Billion by 2032, exhibiting a growth rate (CAGR) of 12.2% during 2024-2032.

Optical coherence tomography (OCT) refers to a non-invasive imaging technique used to obtain high-resolution cross-sectional images of the retina. Tabletop and handheld are some of the commonly available types of OCT devices. They consist of an interferometer and short-pulse lasers with low coherence and a broad bandwidth light source. OCT is widely used in various healthcare domains, such as ophthalmology, oncology, cardiovascular, and dermatology. It is also used to detect the retinal thickness and aids in the early detection and diagnosis of retinal diseases and conditions. It also provides precise imaging of neointimal stent strut coverage in follow-up exams and assists in the easier evaluation of stent strut apposition against the vessel wall.

Optical Coherence Tomography Market Trends:

The increasing incidences of retinal and choroidal disorders and visual impairments across the globe are creating a positive outlook for the market. Optical coherence tomography is widely used by an ophthalmologist for screening and diagnosing retinal-related disorders, including tear and detachment, diabetic retinopathy, macular hole, and retinitis pigmentosa. Apart from this, various product innovations, such as the introduction of higher-performing devices that assist in enhancing accuracy and improving the overall quality of eye care, are providing an impetus to the market growth. Additionally, the increasing geriatric population and rising instances of cancer are also favoring the market growth. Optical coherence tomography aids in early cancer detection and provides information on nuclear-to-cytoplasmic ratio, nuclear size and shape, and the organization and structure of glands. Other factors, including the increasing demand for early diagnosis methods, widespread product utilization in drug delivery, and significant improvements in healthcare technologies, are anticipated to drive the market further toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global optical coherence tomography market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, technology and application.

Breakup by Type:

Handheld OCT Devices

Tabletop OCT Devices

Others

Breakup by Technology:

Time Domain OCT (TDOCT)

Frequency Domain OCT (FD-OCT)

Breakup by Application:

Dermatology

Ophthalmology

Cardiovascular

Oncology

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agfa-Gevaert N.V., Agiltron Inc., Carl Zeiss AG, Haag-Streit Group, Heidelberg Engineering Inc., Leica Microsystems GmbH (Danaher Corporation), Novacam Technologies Inc., OPTOPOL Technology Sp. z o.o., Terumo Corporation, Thorlabs Inc. and Topcon Corporation.

Key Questions Answered in This Report

  • 1. What was the size of the global optical coherence tomography market in 2023?
  • 2. What is the expected growth rate of the global optical coherence tomography market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global optical coherence tomography market?
  • 4. What are the key factors driving the global optical coherence tomography market?
  • 5. What is the breakup of the global optical coherence tomography market based on the type?
  • 6. What is the breakup of the global optical coherence tomography market based on the application?
  • 7. What are the key regions in the global optical coherence tomography market?
  • 8. Who are the key players/companies in the global optical coherence tomography market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Optical Coherence Tomography Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Handheld OCT Devices
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Tabletop OCT Devices
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Time Domain OCT (TDOCT)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Frequency Domain OCT (FD-OCT)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Dermatology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ophthalmology
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Cardiovascular
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Oncology
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Agfa-Gevaert N.V.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Agiltron Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Carl Zeiss AG
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 SWOT Analysis
    • 14.3.5 Haag-Streit Group
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Heidelberg Engineering Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Leica Microsystems GmbH (Danaher Corporation)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Novacam Technologies Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 OPTOPOL Technology Sp. z o.o.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Terumo Corporation
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Thorlabs Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Topcon Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦